Guardian Health
DRC Ebola outbreak could have begun as early as January, WHO chief says
The WHO chief has warned that the DRC's Ebola outbreak may have been circulating since January, giving the virus months to spread undetected before containment efforts began. Dr. Tedros Adhanom Ghebreyesus flagged community mistrust and inadequate contact tracing as major obstacles, compounded by travel restrictions that are disrupting the response rather than aiding it. Officials say they are working to close the gap, but the delayed detection has significantly complicated efforts to bring the outbreak under control.
Read article →Guardian Health
Weight-loss drugs may prevent thousands of knee replacements, study suggests
GLP-1 weight-loss medications may do more than shrink waistlines — a new study finds patients who took the drugs for at least three years faced a significantly reduced risk of needing knee replacement surgery. With knee osteoarthritis affecting tens of millions across the US and UK alone, the implications for surgical waiting lists and healthcare costs could be substantial. Researchers believe the combination of weight reduction and the drugs' anti-inflammatory properties may be driving the effect.
Read article →
Stat News
Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’
Ultra-processed foods have emerged as a rare point of cross-partisan agreement among the public, yet meaningful policy reform remains stalled. Leading researchers in the field are now pushing for systemic change, arguing that the food industry's influence has fundamentally skewed regulatory priorities. Their message is blunt: the current system is designed to protect corporate interests, not public health.
Read article →
Stat News
Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.
Read article →Medical Xpress
New antibiotic kills drug-resistant bacteria by targeting previously unknown vulnerability
McMaster University researchers have discovered manikomycin, a new antibiotic capable of killing dangerous drug-resistant bacteria by exploiting a previously unknown biological vulnerability. The compound has shown early effectiveness against high-priority pathogens including Salmonella, E. coli, and Klebsiella. The finding is significant not just for the drug itself, but for opening an entirely new class of treatments at a time when antibiotic resistance is a growing global health crisis.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →